Cidara Therapeutics, Inc. (CDTX)

NASDAQ: CDTX · IEX Real-Time Price · USD

11.93

-0.11 (-0.91%)

At close: Jul 2, 2024, 4:00 PM

11.70

-0.23 (-1.93%)

After-hours: Jul 2, 2024, 4:02 PM EDT

Cidara Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-22.93	-33.58	-42.47	-74.87	-41.09	Upgrade
Depreciation & Amortization	1.28	1.12	0.19	0.29	0.33	Upgrade
Share-Based Compensation	3.06	3.53	4.01	4.09	5.07	Upgrade
Other Operating Activities	-3.84	0.46	13.03	13.32	7.16	Upgrade
Operating Cash Flow	-22.43	-28.47	-25.23	-54.41	-28.53	Upgrade
Capital Expenditures	-0.51	-0.12	-0.04	-0.19	-0.04	Upgrade
Investing Cash Flow	-0.51	-0.12	-0.04	-0.19	-0.04	Upgrade
Share Issuance / Repurchase	25.98	1.64	49.04	40.24	14.3	Upgrade
Debt Issued / Paid	0	-2.59	-4.44	-2.96	0	Upgrade
Other Financing Activities	-	-	-	-	-0.03	Upgrade
Financing Cash Flow	25.98	-0.95	44.6	37.28	14.27	Upgrade
Net Cash Flow	3.05	-29.54	19.32	-17.32	-14.29	Upgrade
Free Cash Flow	-22.94	-28.59	-25.27	-54.6	-28.57	Upgrade
Free Cash Flow Margin	-35.89%	-44.36%	-50.98%	-452.45%	-136.59%	Upgrade
Free Cash Flow Per Share	-5.25	-8.19	-9.64	-26.27	-19.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).